ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement
February 23, 2021Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology. -
Clovis Oncology completes target enrollment in ATHENA trial in advanced ovarian cancer
June 17, 2020Clovis Oncology announced the completion of target patient enrollment in the Clovis-sponsored Phase 3 ATHENA trial evaluating the combination of Clovis’ Rubraca (rucaparib), a poly (ADP ribose) polymerase inhibitor (PARP) ... -
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
December 03, 2018Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions...
Pharma Sources Insight January 2025
